POLYMED · Healthcare · Medical Instruments & Supplies
Composite scorecard: 55/100 — Quality 69 · Valuation 36 · Growth 88 · Momentum 0
| Share price | ₹1,720.90 |
| Market cap | ₹12,747 Cr |
| P/E ratio | 36.8 |
| P/B ratio | 4.4 |
| ROE | 31.8% |
| ROCE | 16.4% |
| Dividend yield | 0.28% |
| Book value | ₹287.91 |
| Year | Sales | Net profit | OPM |
|---|---|---|---|
| 2026 | ₹1,875 Cr | ₹321 Cr | 24.0% |
| 2025 | ₹1,669 Cr | ₹339 Cr | 27.0% |
| 2024 | ₹1,375 Cr | ₹258 Cr | 26.0% |
| 2023 | ₹1,115 Cr | ₹179 Cr | 24.0% |
| 2022 | ₹922 Cr | ₹147 Cr | 23.0% |
Poly Medicure Limited engages in the manufacture and sale of medical devices in India and internationally. The company offers infusion therapy products, such as I.V Infusion set, extension lines, needle free connector, I.V flow regulator extension set, burette set, three way stop cock, vial access spike, transfer spike, orburator, polyflush, maifolds, polyswab, and arterial blood collection; critical care products, including vial access spikes, arterial cannula, mini mid lines over the wire, extension line, enteral connector, central venous catheters, and huber needle; dialysis and renal care